[HTML][HTML] Network pharmacology and experimental verification to decode the action of Qing Fei Hua Xian Decotion against pulmonary fibrosis

HL Ke, RJ Li, CC Yu, XP Wang, CY Wu, YW Zhang - PloS one, 2024 - journals.plos.org
Background Pulmonary fibrosis (PF) is a common interstitial pneumonia disease, also
occurred in post-COVID-19 survivors. The mechanism underlying the anti-PF effect of Qing …

A network pharmacology approach to explore the potential mechanisms of yifei sanjie formula in treating pulmonary fibrosis

B Qiao, Y Wu, X Li, Z Xu, W Duan, Y Hu… - Evidence‐Based …, 2020 - Wiley Online Library
Objective. Yifei Sanjie Formula (YFSJF) is an effective formula on pulmonary fibrosis (PF),
which has been used in clinic for more than 30 years. In order to investigate the molecular …

[HTML][HTML] Exploring the anti-pulmonary fibrosis mechanism of jingyin granule by network pharmacology strategy

D Zhu, Q Yu, M Jiang, D Wang, Y Shen - Frontiers in Pharmacology, 2022 - frontiersin.org
Pulmonary fibrosis (PF) is a clinically common disease caused by many factors, which will
lead to lung function decline and even respiratory failure. Jingyin granule has been …

[HTML][HTML] Network pharmacology and experimental assessment to explore the pharmacological mechanism of Qimai Feiluoping decoction against pulmonary fibrosis

Y Yang, L Ding, T Bao, Y Li, J Ma, Q Li, Z Gao… - Frontiers in …, 2021 - frontiersin.org
Pulmonary fibrosis (PF) is one of the pathologic changes in COVID-19 patients in
convalescence, and it is also a potential long-term sequela in severe COVID-19 patients …

Mechanism study of Dangshen Pingfei Huoxue decoction in treatment of pulmonary fibrosis based on network pharmacology and molecular docking

WZ ZHANG, XU Yong, ZHU Dong-Wei… - Chinese …, 2023 - pesquisa.bvsalud.org
Aim To explore the potential mechanism of Dangshen Pingfei Huoxue decoction (DPHD) in
the treatment of pulmonary fibrosis. Methods The common targets of DPHD and pulmonary …

Exploring the Mechanisms of the Huangqin Qingfei Decoction in Pneumonia Treatment for Lipopolysaccharide-Induced Mouse Model: A Network Pharmacology …

Z Zheng, J Lei, J Chang, X Yi… - Natural Product …, 2024 - journals.sagepub.com
Objective: In this study, a network pharmacological approach, and in vivo validation
experiments were used to screen the active components of the Huangqin Qingfei decoction …

Investigation of the Mechanism of Action of Qingzaojiufei Decoction on Idiopathic Pulmonary Fibrosis Based on Network Pharmacology and Experimental Validation

C Mao, Y Du, K Niu, F Yang, C Bai… - Natural Product …, 2024 - journals.sagepub.com
Objective: The Traditional Chinese Medicine Qingzao Jiufei Tang decoction (QZJFD) is
effective for the treatment of idiopathic pulmonary fibrosis (IPF). In this study, we explored the …

Effect and mechanism of Qingfei Paidu decoction in the management of pulmonary fibrosis and COVID-19

Y Wu, L Xu, G Cao, L Min, T Dong - The American Journal of …, 2022 - World Scientific
Qingfei Paidu decoction (QFPD) has been repeatedly recommended for the clinical
treatment of novel coronavirus disease 2019 (COVID-19) in multiple provinces throughout …

[HTML][HTML] Elucidating the mechanism of Hongjinshen decoction in the treatment of pulmonary fibrosis based on network pharmacology and molecular docking

H Chen, Y Lin, L Zeng, S Liu - Medicine, 2022 - journals.lww.com
Background: To explore the mechanism of compound Hongginshen decoction in improving
pulmonary fibrosis based on network pharmacology. Methods: The active components and …

Mechanism of Fei‐Xian Formula in the Treatment of Pulmonary Fibrosis on the Basis of Network Pharmacology Analysis Combined with Molecular Docking Validation

XL Chen, C Tang, QL Xiao, ZH Pang… - Evidence‐Based …, 2021 - Wiley Online Library
Objective. This study aimed to clarify the mechanism of Fei‐Xian formula (FXF) in the
treatment of pulmonary fibrosis based on network pharmacology analysis combined with …